Researchers have succeeded in taking the next step toward using human-made nanoscale compounds in the fight against cancer. A recent proof-of-concept study showed that dendrimers -- which were first introduced in the 1980s -- may be used to introduce compounds that essentially trick cancer cells into performing self-destructive tasks.